Indian Ipratropium Exporters: Complete Supplier Ranking with Market Share — 173 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ipratropium supplier from India?

CIPLA LIMITED is the largest ipratropium exporter from India with a 84.7% market share and export value of $48.3M.

Q: How many ipratropium suppliers are there in India?

There are 173 active ipratropium exporters in India, collectively shipping $57.1M worth of ipratropium across 2,297 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ipratropium suppliers from India?

The top 5 ipratropium suppliers from India — CIPLA LIMITED, AHLCON PARENTERALS (INDIA) LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ALTHEA PHARMA PRIVATE LIMITED, AHLCON PARENTERALS INDIA LIMITED — together control 95.0% of total ipratropium export value from India.

Suresh Sormare

Ipratropium

India Pharmaceutical Trade Intelligence

$57.1M173 Suppliers81 CountriesHS 30049099

ExportsIndia → SOUTH AFRICA55.2%India → UNITED STATES28.5%

#1 Supplier: CIPLA LIMITED

Ipratropium Suppliers from India (2026) — 173 Exporters, $57.1M Market | TransData Nexus | TransData Nexus

Who Exports Ipratropium from India — 173 Suppliers Behind a $57.1M Market

India's ipratropium export market is supplied by 173 active exporters who collectively shipped $57.1M across 2,297 shipments. CIPLA LIMITED leads with a 84.7% market share, followed by AHLCON PARENTERALS (INDIA) LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 95.0% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Ipratropium Suppliers & Exporters — 173 manufacturers, $57.1M export market, top destinations and formulations — Ipratropium supplier data — 173 exporters · $57.1M market · 2,297 shipmentsTransData Nexus · Indian Customs Data

Top Ipratropium Exporters from India — Ranked by Export Value

CIPLA LIMITED is the leading ipratropium exporter from India, holding a 84.7% share of the $57.1M market across 2,297 shipments from 173 exporters. The top 5 suppliers — CIPLA LIMITED, AHLCON PARENTERALS (INDIA) LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ALTHEA PHARMA PRIVATE LIMITED, AHLCON PARENTERALS INDIA LIMITED — collectively control 95.0% of total export value, indicating a highly concentrated market. Individual shares are: CIPLA LIMITED (84.7%), AHLCON PARENTERALS (INDIA) LIMITED (4.4%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (4.0%), ALTHEA PHARMA PRIVATE LIMITED (1.2%), AHLCON PARENTERALS INDIA LIMITED (0.8%).

Top Ipratropium Exporters from India

Ranked by export value · 173 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Ipratropium Exporters from India — Ranked by Export Value. 173 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Ipratropium exporters

Certification and compliance status for top Ipratropium suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
CIPLA LIMITED	Approved	Yes	Yes	Multiple	Cipla Limited holds FDA approval, WHO-GMP, and EU GMP certifications.
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Approved	Yes	Yes	Multiple	Sun Pharmaceutical Industries Limited holds FDA approval, WHO-GMP, and EU GMP ce
AHLCON PARENTERALS (INDIA) LIMITED	Not Listed	Yes	No	Not Applicable	Ahlcon Parenterals (India) Limited holds WHO-GMP certification.
AXA PARENTERALS LIMITED	Not Listed	Yes	No	Not Applicable	AXA Parenterals Limited holds WHO-GMP certification.
AKRITI PHARMACEUTICALS PVT. LTD	Not Listed	Yes	No	Not Applicable	Akriti Pharmaceuticals Pvt. Ltd holds WHO-GMP certification.

TransData Nexus reviewed the regulatory standing of 5 leading Ipratropium exporters from India. 2 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Ipratropium sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as India's "Bulk Drug Capital," is a pivotal center for active pharmaceutical ingredient (API) manufacturing. The city's Genome Valley hosts numerous R&D and biologics firms, while industrial areas like Bollaram and Pashamylaram are home to API and intermediate manufacturers. The ongoing development of Hyderabad Pharma City aims to integrate APIs, formulations, and support services within a unified cluster, enhancing production efficiency and scalability.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical formulations industry. Ahmedabad, housing companies like Cadila Pharmaceuticals, focuses on producing a wide range of pharmaceutical products, including generic drugs and active pharmaceutical intermediates. Vadodara complements this with its manufacturing capabilities, contributing significantly to the region's pharmaceutical output.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Mumbai, the headquarters of major companies like Sun Pharmaceutical Industries Limited and Cipla Limited, facilitates global distribution through its well-established infrastructure and proximity to major ports. Thane and Raigad districts support this with manufacturing facilities and R&D centers, enhancing the region's export capabilities.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Ipratropium exporters from India

April 2024

Acquisition

CIPLA LIMITED — Cipla acquires Ivia Beaute's personal care brands for ₹130 crore

In April 2024, Cipla Limited acquired the distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore, with an additional ₹110 crore contingent on milestones. This acquisition aims to expand Cipla's consumer health portfolio into personal care products. IMPACT: This strategic move is expected to diversify Cipla's revenue streams, potentially enhancing its financial stability and supporting sustained Ipratropium export levels.

Impact: This strategic move is expected to diversify Cipla's revenue streams, potentially enhancing its financial stability and supporting sustained Ipratropium export levels.

March 2023

Acquisition

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires Concert Pharmaceuticals for $576 million

In March 2023, Sun Pharmaceutical Industries Limited completed the acquisition of Concert Pharmaceuticals, Inc., a U.S.-based biotechnology company, for $576 million. This acquisition is intended to bolster Sun Pharma's dermatology portfolio. IMPACT: While primarily enhancing Sun Pharma's dermatology offerings, the acquisition may lead to increased financial resources, indirectly supporting the company's Ipratropium export capabilities.

Common Questions — Ipratropium Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which ipratropium supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, CIPLA LIMITED leads with 402 recorded shipments worth $48.3M. AHLCON PARENTERALS (INDIA) LIMITED (53 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (153 shipments) are also established high-volume exporters.

Q How many ipratropium manufacturers are there in India?

India has 173 active ipratropium exporters with a combined export market of $57.1M across 2,297 shipments to 81 countries. The top 5 suppliers hold 95.0% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for ipratropium from India?

Average FOB unit price: $9.01 per unit, ranging from $0.01 to $11607.35. Average shipment value: $24.8K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ipratropium

Ipratropium

Who Exports Ipratropium from India — 173 Suppliers Behind a $57.1M Market

Top Ipratropium Exporters from India — Ranked by Export Value

Top Ipratropium Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

CIPLA LIMITED — Cipla acquires Ivia Beaute's personal care brands for ₹130 crore

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires Concert Pharmaceuticals for $576 million

Common Questions — Ipratropium Suppliers from India

Q Which ipratropium supplier from India is the most reliable for bulk orders?

Q How many ipratropium manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for ipratropium from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma merges with Taro Pharmaceuticals in $347.73 million deal

Analysis Methodology